Liu, L., Wang, J., Li, Y., Chen, F., Yan, B., Zeng, Y., Xiang, Z. (2026). A phase II study of perioperative cadonilimab (AK104) in patients with recurrent resectable head and neck squamous cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2529